+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07845617

Evaluating Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases in Pancreatic and Duodenal Adenocarcinoma Patients A Prospective Observational Study

Led by AdventHealth · Updated on 2026-09-29

10

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This observational study evaluates the use of hepatic artery infusion pump HAIP chemotherapy in patients with pancreatic or duodenal adenocarcinoma who have isolated or liver-dominant metastases following surgery and systemic chemotherapy. The study aims to assess liver tumor response using imaging criteria RECIST and measure outcomes such as progression-free survival and overall survival. It is a prospective feasibility study enrolling adult patients with confirmed diagnoses who are appropriate candidates for HAIP treatment. Participants will undergo placement of a hepatic artery infusion pump as part of their standard clinical care. They will receive floxuridine FUDR-based chemotherapy delivered through the pump. This study does not introduce experimental treatments but collects data during routine care. Treatment decisions including timing and regimen are made by the treating oncology team. Participants will be followed for up to five years after pump placement to track long-term outcomes. During the study, clinical data including imaging results, laboratory tumor markers such as ctDNA, CEA, and CA 19-9, and treatment details will be collected from medical records. There are no additional study-specific visits or procedures beyond standard care. The research team will measure progression-free survival, hepatic disease control rate, overall survival, and monitor complications related to surgery, catheter use, and chemotherapy. Data privacy will be maintained through de-identification and secure storage.

CONDITIONS

Brief Title

Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma

Research Team

M

Maggie Polanco, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here